An evaluation of NMP 22 urinary level and flow cytometry for diagnosing bladder transitional cell carcinoma.

沈周俊,金晓东,蔡松良
DOI: https://doi.org/10.3760/j:issn:1000-6702.2001.11.006
2001-01-01
Abstract:Objective To evaluate the diagnostic value of three non-invasive tests for bladder transitional cell carcinoma. Methods 85 patients were divided into three groups:bladder transi tional cell carcinoma,benign diseases of urinary system and no-urothelium mal ignancy of urinary system. All patients were asked to submit a single voided u rine sample before operation. Each sample was divided into 3 aliquots,and NMP 22 ?FCM?cytological examination were performed respectively. Results Median NMP 22 value for BTCC group was 16.1U/ml,for benign disease group 7.2U/ml, and for no-urothelium malignancy of urology group 4.5U/ml. The u rinary NMP 22 values in the BTCC group were significantly higher than the oth er two groups (P0.05).The sensitivity of NMP 22, FCM,and cytology for th e diagnosis of BTCC was 61.1%, 69.4%, 18.3%, with a specificity of 67.4%, 59.2%, and 100% respectively. Conclusions Urinary NMP 22 assa y and FCM are the useful diagnostic adjunct to the conventional urine cytologic examination for the detection of BTCC.
What problem does this paper attempt to address?